National Stigma Survey About Mental Illness, Intellectual Disability and Homelessness in Spain
NCT ID: NCT05174962
Last Updated: 2022-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2750 participants
OBSERVATIONAL
2022-01-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Stigma is associated with the condition of being different, and affects any person belonging to a minority or vulnerable group, being one of the main obstacles to full participation in different social, political and cultural institutions. The fight against stigma is included in important international treaties, such as the United Nations Convention on the Rights of Persons with Disabilities or the European recommendations regarding the fight against social exclusion of people with mental health problems.
This study will focus on three groups of special social sensitivity, with clear stigmatizing conditions: people with mental health problems, people in a homeless situation and people with intellectual disabilities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Group Identity on the Community Integration of People With Severe Mental Disorder
NCT04304417
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum
NCT01805128
CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project
NCT06453174
Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders
NCT05017532
Cognitive Remediation Therapy and Schizophrenia
NCT01078129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
From this general aim, four different specific goals are derived: 1) To delve into the experience of stigma of these groups, from first person; 2) To develop a quantitative assessment instrument that captures the current needs and experiences of people from these groups; 3) To describe and compare the social stigma of these three groups in a representative Spanish sample; 4) To address, from a gender perspective, possible differences in terms of the variables explored in the populations under study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any gender.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grupo 5
UNKNOWN
Universidad Complutense de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Muñoz, Ph.D.
Role: STUDY_CHAIR
Universidad Complutense de Madrid
Manuel Muñoz, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Universidad Complutense de Madrid
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/21-026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.